Abdelrahman Hamdi

Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, <i>in vitro</i> and <i>in silico</i> studies

Dina I. A. Othman, Abdelrahman Hamdi, Samar S. Tawfik et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 69 citations · Full text

New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and <i>in silico</i> study

Mohammad M. Al‐Sanea, Abdelrahman Hamdi, Ahmed A. B. Mohamed et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 44 citations · Full text

Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study

Noura F.M. El Hamaky, Abdelrahman Hamdi, Waleed A. Bayoumi et al. · Bioorganic Chemistry · 2024 · 36 citations

Combinatorial Chemistry, Medicinal Chemistry, Natural Sciences +7

Design, synthesis, antitumor, and VEGFR-2 inhibition activities of novel 4-anilino-2-vinyl-quinazolines: Molecular modeling studies

Abdelrahman Hamdi, Hamed W. El-Shafey, Dina I. A. Othman et al. · Bioorganic Chemistry · 2022 · 28 citations

Medicinal Chemistry, Engineering, Medicine +10

Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2,4-dione derivatives: Histone deacetylases inhibitory activity and molecular docking study

Abdelrahman Hamdi, Walaa M. El-Husseiny, Dina I. A. Othman et al. · European Journal of Medicinal Chemistry · 2022 · 26 citations · Full text

Inhibitory Activity, Medicinal Chemistry, Biochemistry +10